Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: J Pharmacokinet Pharmacodyn. 2016 Sep 16;43(5):461–479. doi: 10.1007/s10928-016-9490-0

Table 1.

Properties of the presented CETs

CET Equation Construction principle Symmetry Positivity Scaling Diagonality Maximal combination effect EmaxAB Inhibitory form
Competitive Equation (18) DRBKa Yes Yes Yes Yes max {EmaxA;EmaxB} Yes
Uncompetitive Equation (22) DRBKa No Yes Yes (1+ β′)EmaxA Yes for β′ ≤ 0
Non-competitive Equation (24) DRBKa No Yes Yes (1+ β′)EmaxA Yes for β′ ≤ 0
Loewe Equation (29) ADDb Yes Yes Yes Yes Emax Yes
Bliss Equation (33) ADDb Yes Yes Yes Yes Emax Yes
Greco Equation (37) ADDb Yes No Yes Yes Emax Yes
Summation Equation (39) EmpSUMc Yes Yes Yes No EmaxA + EmaxB No
Inhibitory Equation (42) IDRd Yes Yes No No ImaxA + ImaxBImaxAImaxB
Stimulation Equation (43) IDRd Yes Yes No No EmaxA + EmaxB + EmaxAEmaxB No
a

Drug-receptor binding kinetics

b

Additive approaches

c

Empirical summation approaches

d

Indirect response models